Not a good buy right now: trend is decisively bearish (SMA_200 > SMA_20 > SMA_5) and momentum is still deteriorating (MACD histogram negative and expanding).
Price ($1.20) is sitting just above near-term support (S1 ~$1.184). With no proprietary buy signals, risk of a support break outweighs the immediate upside for an impatient entry.
Best tactical stance today: hold/avoid new longs until the stock reclaims the pivot (~$1.314) or shows a confirmed bounce off support with improving momentum.
Technical Analysis
Trend: Bearish structure with stacked moving averages (SMA_200 > SMA_20 > SMA_5), indicating a sustained downtrend.
Momentum: MACD histogram -0.0121 below zero and negatively expanding => downside momentum is strengthening, not stabilizing.
RSI: RSI_6 ~24 indicates deeply oversold conditions (despite the provided label), which can lead to short bounces, but oversold alone is not a buy signal in a strong downtrend.
Levels to watch:
Support: S1 ~$1.184 (very close), then S2 ~$1.104.
Resistance: Pivot ~$1.314, then R1 ~$1.444.
Pattern-based forward bias (similar candlesticks): modestly positive drift projected (+0.46% next day, +1.07% next week, +6.06% next month), but this conflicts with current weakening momentum—treat as low-conviction until trend improves.
could spark a short-term relief move if support holds.
Neutral/Negative Catalysts
Downtrend remains intact and momentum is still worsening (negative, expanding MACD histogram).
If $1.184 breaks, next technical air pocket is toward ~$1.104 (S2), implying immediate downside risk.
No recent news flow (no fresh catalysts) and no proprietary buy signals today reduces odds of a timely upside move.
Profitability remains negative (net income still a loss) and gross margin declined materially YoY, pressuring the fundamental recovery narrative.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: $13.851M, down -0.23% YoY (flat-to-slightly down growth).
Net income: -$3.651M, improved 295.99% YoY (loss narrowing meaningfully, but still negative).
EPS: -0.75, improved 82.93% YoY (still negative).
Gross margin: 19.72%, down -13.05% YoY (margin compression is a key negative trend).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price target change data was provided, so the recent trend in Wall Street upgrades/downgrades cannot be assessed.
Wall Street pros/cons view (based only on provided data):
Pros: losses improving materially YoY; potential oversold bounce; upcoming earnings as a catalyst.
Cons: revenue flat/down, gross margin deterioration, and technicals firmly bearish with weakening momentum.
Wall Street analysts forecast IMCC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IMCC is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast IMCC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IMCC is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
